UBS AM’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$115M Sell
1,476,376
-5,307,192
-78% -$415M 0.02% 509
2025
Q1
$492M Buy
6,783,568
+264,311
+4% +$19.2M 0.13% 168
2024
Q4
$483M Buy
6,519,257
+513,468
+9% +$38M 0.11% 163
2024
Q3
$396M Buy
6,005,789
+61,275
+1% +$4.04M 0.1% 179
2024
Q2
$549M Buy
5,944,514
+1,545,063
+35% +$143M 0.16% 116
2024
Q1
$420M Buy
4,399,451
+406,989
+10% +$38.9M 0.15% 135
2023
Q4
$304M Buy
3,992,462
+130,458
+3% +$9.95M 0.12% 171
2023
Q3
$268M Sell
3,862,004
-82,832
-2% -$5.74M 0.12% 172
2023
Q2
$326M Hold
3,944,836
0.16% 132
2023
Q1
$326M Buy
3,944,836
+185,662
+5% +$15.4M 0.16% 132
2022
Q4
$280M Buy
3,759,174
+72,201
+2% +$5.39M 0.15% 163
2022
Q3
$305M Sell
3,686,973
-904,201
-20% -$74.7M 0.17% 127
2022
Q2
$437M Sell
4,591,174
-263,361
-5% -$25M 0.23% 84
2022
Q1
$571M Sell
4,854,535
-1,745,067
-26% -$205M 0.24% 81
2021
Q4
$855M Buy
6,599,602
+2,198,164
+50% +$285M 0.33% 59
2021
Q3
$498M Buy
4,401,438
+93,674
+2% +$10.6M 0.21% 106
2021
Q2
$446M Buy
4,307,764
+672,520
+18% +$69.7M 0.19% 111
2021
Q1
$304M Sell
3,635,244
-914,799
-20% -$76.5M 0.13% 159
2020
Q4
$415M Sell
4,550,043
-1,207,794
-21% -$110M 0.19% 105
2020
Q3
$460M Buy
5,757,837
+524,179
+10% +$41.8M 0.25% 82
2020
Q2
$362M Buy
5,233,658
+63,053
+1% +$4.36M 0.22% 90
2020
Q1
$325M Buy
5,170,605
+385,848
+8% +$24.3M 0.23% 85
2019
Q4
$372M Buy
4,784,757
+1,259,940
+36% +$98M 0.23% 85
2019
Q3
$258M Buy
3,524,817
+723,978
+26% +$53.1M 0.17% 117
2019
Q2
$172M Buy
2,800,839
+221,559
+9% +$13.6M 0.12% 183
2019
Q1
$164M Buy
2,579,280
+218,124
+9% +$13.9M 0.12% 191
2018
Q4
$121M Buy
2,361,156
+129,888
+6% +$6.63M 0.1% 218
2018
Q3
$129M Sell
2,231,268
-3,483
-0.2% -$202K 0.1% 233
2018
Q2
$108M Buy
2,234,751
+21,738
+1% +$1.05M 0.08% 278
2018
Q1
$103M Buy
2,213,013
+275,427
+14% +$12.8M 0.08% 284
2017
Q4
$72.8M Buy
1,937,586
+80,907
+4% +$3.04M 0.06% 340
2017
Q3
$67.7M Buy
1,856,679
+23,493
+1% +$856K 0.06% 336
2017
Q2
$72.3M Buy
1,833,186
+110,808
+6% +$4.37M 0.07% 306
2017
Q1
$54M Buy
1,722,378
+124,908
+8% +$3.92M 0.06% 375
2016
Q4
$49.9M Sell
1,597,470
-52,956
-3% -$1.65M 0.06% 370
2016
Q3
$66.3M Buy
1,650,426
+57,216
+4% +$2.3M 0.07% 300
2016
Q2
$53M Sell
1,593,210
-12,066
-0.8% -$401K 0.06% 348
2016
Q1
$47.2M Buy
1,605,276
+13,089
+0.8% +$385K 0.05% 372
2015
Q4
$41.9M Sell
1,592,187
-334,287
-17% -$8.8M 0.05% 412
2015
Q3
$45.6M Sell
1,926,474
-1,233,246
-39% -$29.2M 0.05% 403
2015
Q2
$75M Sell
3,159,720
-84,330
-3% -$2M 0.07% 298
2015
Q1
$77M Sell
3,244,050
-84,414
-3% -$2M 0.07% 289
2014
Q4
$70.7M Sell
3,328,464
-499,800
-13% -$10.6M 0.07% 311
2014
Q3
$65.2M Buy
3,828,264
+899,916
+31% +$15.3M 0.06% 318
2014
Q2
$41.9M Buy
2,928,348
+184,302
+7% +$2.64M 0.04% 463
2014
Q1
$33.9M Buy
2,744,046
+202,116
+8% +$2.5M 0.04% 503
2013
Q4
$27.9M Buy
2,541,930
+211,218
+9% +$2.31M 0.03% 535
2013
Q3
$27M Buy
2,330,712
+421,830
+22% +$4.9M 0.03% 510
2013
Q2
$21.4M Buy
+1,908,882
New +$21.4M 0.03% 552